Resurgent Biosciences

From Cannabis MSO To Drug Development: Goodness Growth Wants To Understand Traditional Psychedelics Use

Resurgent Biosciences, a subsidiary of Goodness Growth Holdings, Inc. (CSE: GDNS) (OTCQX: GDNSF), is launching a survey study that will look into the varying effects of entheogen and psychedelic experiences for therapeutic, religious and spiritual purposes.

Vireo Health Announces Name Change And Plans To Begin Psychedelics Research and IP Development Expansion

Goodness Growth Holdings, Inc., announced that its subsidiary, Resurgent Biosciences, plans to expand its IP property into the psychedelics space. Unlike the company's cannabis offerings, the new endeavor will not touch psychedelics for commercial production.